Filing Details

Accession Number:
0001493152-22-035280
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-13 11:44:54
Reporting Period:
2022-12-12
Accepted Time:
2022-12-13 11:44:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335105 Lixte Biotechnology Holdings Inc. LIXT Pharmaceutical Preparations (2834) 202903526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1939159 Rene Bernards Koningsvaren 37
Abcoude P7 1391AD
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-12 10,000 $0.61 135,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct